Innovation for Health - 14 February 2019
Global Investor Forum Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Keynote speakers

Transforming healthcare through ...

Our healthcare system is changing rapidly, not only by social-economic factors and demographics, but also by scientific breakthroughs and technological innovations.

How will healthcare be transformed through Big Data? In what ways is Biotech impacting drug development and healthcare? How will robotics and artificial intelligence redefine the healthcare landscape? The future of healthcare is not only determined by technological innovations, but also by ethical aspects. What ethical issues are we facing due to these innovations?

Find out what keynote speakers contributed to the program of Innovation for Health 2018:

Transformation healthcare through Big Data

Barend Mons, Scientific Lead DTL Data
Barend Mons is a molecular biologist and biosemantics specialist. He is known for innovations in scholarly collaboration, especially nanopublications and the FAIR data initiative. He is Professor in Bio-Semantics at the Department of Human Genetics at the Leiden University Medical Centre. He is also affiliated with the Erasmus Medical Centre and appointed chair of the High Level Expert Group on the European Open Science Cloud. His present activities mainly focus on international knowledge sharing and networking to realize a completely new form of Computer Assisted Distributed Annotation and on-line knowledge discovery in close collaboration with The Dutch Techcenter for the Life Sciences.

Transformation healthcare through Robotics

Maarten Steinbuch, Distinguished University Professor, Eindhoven University of Technology
Maarten Steinbuch is since 1999 full professor and chair of the Control Systems Technology group of the Mechanical Engineering Department at Eindhoven University of Technology. Since 2014 he is also Scientific Director of the TU/e High Tech Systems Center HTSC. In 2013 he was appointed Distinguished University Professor at TU/e. In 2015 Maarten received the KIVI Academic Society Award. In 2016 he received the STW Simon Stevin Meester 2016 award, the highest Dutch award for Science and Technology. He is co-founder of Mechatronics Academy BV, Preceyes BV, Microsure BV, and CEO of Medical Robotic Technologies BV.

Transformation healthcare through Ethics

Annelien Bredenoord, Professor of Ethics of Biomedical Innovation, UMC Utrecht
Annelien Bredenoord is Professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht, as well as member of the Senate of Dutch Parliament (D66).
Her research group seeks to identify, evaluate and promote policies and practices that ensure that biomedical innovation (with a focus on regenerative medicine, biobanking, Big Data, genomics, reproductive technologies) develops in an ethically and socially responsible matter: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way? Bredenoord co-authored over 70 articles and supervises several PhD students.

Transformation healthcare through Biotech

Jan van de Winkel, President and Chief Executive Officer of Genmab
Jan van de Winkel is co-founder, President and CEO of Genmab. Genmab is focused on developing innovative antibody therapeutics for cancer. Jan van de Winkel has overseen the creation and development of a number of human antibodies for the treatment of cancer and other diseases. Jan van de Winkel played a key role as CSO for the first 11 years before he became President and CEO in 2010 to develop the antibody company to a fully independent commercial enterprise. Since its foundation in 1999, Genmab has become the largest biotechnology company in Europe.

Driving innovation through public-private partnerships

Travis McCready, President and CEO of the Massachusetts Life Sciences Center
Travis McCready is the President and CEO of the Massachusetts Life Sciences Center, a $1 billion public–private partnership with the mission of advancing the life sciences sector in Massachusetts. He directs and oversees the center’s investment strategy, along with the agency’s operations, programs, and partnerships. Previously, Mr. McCready served as the Vice President for Programs at The Boston Foundation, directing the Foundation’s grants and community investment strategy to benefit the people of Greater Boston. Prior to that, he was the first Executive Director of the Kendall Square Association, responsible for growing the innovation economy of Kendall Square, one of the Commonwealth’s most economically robust districts. He has also held the Chief Operating Officer and CFO positions at the Massachusetts Convention Center Authority, overseeing the operations and finances for the three convention centers in Massachusetts.
Calling entrepreneurs for pitches!

Are you looking to raise capital or to find partners to co-develop your healthcare solution? Do you want more exposure for your company and your products amongst decision makers in health & Life Sciences? We have room for 10 start-ups and 6 scale-up companies to pitch their healthcare innovation to key players in Health & Life Sciences.
More information

Calling entrepreneurs for pitches!
Contribute as sponsor, speaker or exhibitor!

Do you want to capture the attention of our 800+ high-level attendees in key positions? Then join the sixth edition of Innovation for Health and benefit from the diverse sponsorship & exhibition opportunities that this conference has to offer you. Have a look at our participation brochure or contact us at +31(0)35 628 6659 to discuss the possibilities.
Download participation brochure

Contribute as sponsor, speaker or exhibitor!
Global Investor Forum & I4H join forces (again)!

We are very pleased to announce that, after a succesful partnership with the Global Investor Forum last year, we will again join forces for the next edition on 14 February 2019. Last year, this partnership resulted in being the biggest venture capital forum in the Netherlands dedicated specifically to Life Sciences & Health.  More info about GIF

Global Investor Forum & Innovation for Health join forces!
Sponsors & Partners
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
Your logo?
Become a sponsor of Innovation for Health 2019!
© 2018 Innovation for Health